Profile
| Metric | Value |
|---|---|
| Full Name | Zimmer Biomet Holdings, Inc. |
| Ticker | NYSE: ZBH |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | |
| Website | zimmerbiomet.com |
| Employees | 17,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $90.02 | |
| Price, 1D Change | +0.11% | |
| Market Cap | $18B | |
| TTM Dividend Yield | 1.07% | |
| PE Ratio | 22.28 | |
| Beta | 0.31 | |
| Revenue | $8B | |
| Revenue, 1Y Change | +3.85% | |
| EPS | $4.43 | |
| EPS, 1Y Change | -9.23% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.24 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 103:100 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ZMH | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $4.43 | |
| EPS Estimate | $8.17 | |
| EPS Est. Change | +84.28% | |
| Revenue | $7.68B | |
| Revenue Estimate | $8.21B | |
| Revenue Est. Change | +6.91% | |
| Current Price | $90.02 | |
| Price Target | - | $100.00 |
| Price Tgt. Change | - | +11.09% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $7.51 | $4.88 | -34.98% | |
| $7.98 | $4.43 | -44.44% | |
| $8.17 | N/A | +84.28% | |
| $8.50 | N/A | +91.84% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $7.38B | $7.39B | +0.17% | |
| $7.67B | $7.68B | +0.13% | |
| $8.21B | N/A | +6.91% | |
| $8.63B | N/A | +12.45% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -13.82% | |
| Price, 3Y | -29.40% | |
| Market Cap, 1Y | -14.21% | |
| Market Cap, 3Y | -33.05% | |
| Revenue, 1Y | +3.85% | |
| Revenue, 3Y | +12.47% | |
| EPS, 1Y | -9.23% | |
| EPS, 3Y | +132.22% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $90.02 | |
| SMA 200 | $97.50 | |
| SMA 200 vs Price | +8.31% | |
| SMA 50 | $93.42 | |
| SMA 50 vs Price | +3.78% | |
| Beta | 0.31 | |
| ATR | $1.79 | |
| 14-Day RSI | 42.54 | |
| 10-Day Volatility | 13.25% | |
| 1-Year Volatility | 30.98% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.24 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 1.07% | |
| Total Dividend | $0.96 | |
| Dividends Paid | $196.00M | |
| Payout Ratio | 21.65% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $7.68B | |
| EPS | $4.43 | |
| Gross Profit | $4.82B | |
| Gross Margin | 62.79% | |
| Operating Profit | $1.49B | |
| Operating Margin | 19.34% | |
| Net Income | $905.20M | |
| Net Margin | 11.79% | |
| EBITDA | $2.48B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.51 | |
| Current Ratio | 1.91 | |
| Quick Ratio | 0.99 | |
| - | ||
| F-Score | 7 | |
| Altman Z-Score | 2.64 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 22.28 | |
| PS Ratio | 2.23 | |
| PB Ratio | 1.40 | |
| EV/EBITDA | 9.68 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $12.47B | |
| Cash & Equivalents | $525.50M | |
| Total Assets | $21.37B | |
| Current Assets | $4.67B | |
| Total Liabilities | $8.89B | |
| Current Liabilities | $2.45B | |
| Total Debt | $6.39B | |
| Short Term Debt | $863.00M | |
| Accounts Payable | $184.20M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $6.77B | |
| Operating Expenses | $3.34B | |
| Cost Of Goods Sold | $2.86B | |
| SG&A | $0.00 | |
| D&A | $996.30M | |
| Interest Expense | $0.00 | |
| Income Tax | $131.40M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $1.50B | |
| CFI | -$888.10M | |
| CFF | -$484.50M | |
| Capex | $597.10M | |
| Free Cash Flow | $902.30M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Baird | → | |
| Citigroup | → | |
| Canaccord Genuity | → | |
| UBS | → | |
| RBC Capital | → | |
| JP Morgan | → | |
| Barclays | → | |
| Barclays | → | |
| BTIG | → | |
| Canaccord Genuity | → |
Analyst sentiment
Institutional ownership
Screeners with ZBH
Data Sources & References
- ZBH Official Website www.zimmerbiomet.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1136869/000119312525266884/0001193125-25-266884-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1136869/000095017025026604/0000950170-25-026604-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- ZBH Profile on Yahoo Finance finance.yahoo.com/quote/ZBH
- ZBH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/zbh
FAQ
What is the ticker symbol for Zimmer Biomet Holdings, Inc.?
The ticker symbol for Zimmer Biomet Holdings, Inc. is NYSE:ZBH
Does Zimmer Biomet Holdings, Inc. pay dividends?
Yes, Zimmer Biomet Holdings, Inc. pays dividends. The last payment was $0.24, with an ex-dividend date on December 30, 2025
What sector is Zimmer Biomet Holdings, Inc. in?
Zimmer Biomet Holdings, Inc. is in the Healthcare sector
What industry is Zimmer Biomet Holdings, Inc. in?
Zimmer Biomet Holdings, Inc. is in the Medical Devices industry
What country is Zimmer Biomet Holdings, Inc. based in?
Zimmer Biomet Holdings, Inc. is headquartered in United States
When did Zimmer Biomet Holdings, Inc. go public?
Zimmer Biomet Holdings, Inc. initial public offering (IPO) was on July 25, 2001
Is Zimmer Biomet Holdings, Inc. in the S&P 500?
Yes, Zimmer Biomet Holdings, Inc. is included in the S&P 500 index
Is Zimmer Biomet Holdings, Inc. in the NASDAQ 100?
No, Zimmer Biomet Holdings, Inc. is not included in the NASDAQ 100 index
Is Zimmer Biomet Holdings, Inc. in the Dow Jones?
No, Zimmer Biomet Holdings, Inc. is not included in the Dow Jones index
When was Zimmer Biomet Holdings, Inc. last earnings report?
Zimmer Biomet Holdings, Inc.'s most recent earnings report was on November 5, 2025
When does Zimmer Biomet Holdings, Inc. report earnings?
The next expected earnings date for Zimmer Biomet Holdings, Inc. is February 5, 2026
